Hass HG - Search Results

1

Signet ring cell carcinoma of the stomach is significantly associated with poor prognosis and diffuse gastric cancer (Lauren's): single-center experience of 160 cases.

Hass HG, Smith U, Jäger C, Schäffer M, Wellhäuber U, Hehr T, Markmann HU, Nehls O, Denzlinger C. Hass HG, et al. Onkologie. 2011;34(12):682-6. doi: 10.1159/000334545. Epub 2011 Nov 21. Onkologie. 2011. PMID: 22156447

2

Gene expression analysis for evaluation of potential biomarkers in hepatocellular carcinoma.

Hass HG, Jobst J, Scheurlen M, Vogel U, Nehls O. Hass HG, et al. Anticancer Res. 2015 Apr;35(4):2021-8. Anticancer Res. 2015. PMID: 25862856

3

Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis B.

Hass HG, Bock T, Nehls O, Kaiser S. Hass HG, et al. J Gastroenterol. 2009;44(8):871-7. doi: 10.1007/s00535-009-0078-y. Epub 2009 May 21. J Gastroenterol. 2009. PMID: 19458896

4

DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.

Hass HG, Schmidt A, Nehls O, Kaiser S. Hass HG, et al. Oral Oncol. 2008 Jan;44(1):78-85. doi: 10.1016/j.oraloncology.2006.12.013. Epub 2007 Mar 9. Oral Oncol. 2008. PMID: 17350326

5

Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.

Hass HG, Jobst J, Vogel U, Scheurlen M, Nehls O. Hass HG, et al. Oncol Res Treat. 2014;37(12):732-8. doi: 10.1159/000369151. Epub 2014 Nov 21. Oncol Res Treat. 2014. PMID: 25531719

6

Prognostic implications of BAX protein expression and microsatellite instability in all non-metastatic stages of primary colon cancer treated by surgery alone.

Nehls O, Hass HG, Okech T, Zenner S, Hsieh CJ, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Porschen R, Gregor M, Klump B. Nehls O, et al. Among authors: hass hg. Int J Colorectal Dis. 2009 Jun;24(6):655-63. doi: 10.1007/s00384-009-0635-0. Epub 2009 Feb 17. Int J Colorectal Dis. 2009. PMID: 19221769

7

Thyroid disorders and occurrence of nonorgan-specific autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1).

Hass HG, Klein R, Nehls O, Kaiser S. Hass HG, et al. J Clin Gastroenterol. 2009 May-Jun;43(5):470-6. doi: 10.1097/MCG.0b013e318184a470. J Clin Gastroenterol. 2009. PMID: 19247202 Clinical Trial.

8

Long-term treatment of advanced hepatocellular carcinoma with the tyrosine kinase inhibitor erlotinib (Tarceva)--a case report.

Hass HG, Denzlinger C. Hass HG, et al. Z Gastroenterol. 2009 Jan;47(1):27-9. doi: 10.1055/s-2008-1027482. Epub 2009 Jan 20. Z Gastroenterol. 2009. PMID: 19156589

9

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial.

Nehls O, Klump B, Arkenau HT, Hass HG, Greschniok A, Gregor M, Porschen R. Nehls O, et al. Among authors: hass hg. Br J Cancer. 2002 Sep 23;87(7):702-4. doi: 10.1038/sj.bjc.6600543. Br J Cancer. 2002. PMID: 12232749 Free PMC article. Clinical Trial.

10

Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis.

Hass HG, Nehls O, Jobst J, Frilling A, Vogel U, Kaiser S. Hass HG, et al. World J Gastroenterol. 2008 Apr 28;14(16):2501-10. doi: 10.3748/wjg.14.2501. World J Gastroenterol. 2008. PMID: 18442196 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters